Get Started

PMCB

NASD PharmaCyte Biotech, Inc.
Oct 31, 2026 · 2:02 PM ET EOD Market Closed

$0.3021 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.3021, $0.0379 below the day’s high of $0.3400

YTD change
-58.27%
vs 20-day SMA
-17.05%
vs 200-day SMA
-53.35%

Price ranges

Previous day
$0.3021 $0.3400
open $0.3390 close $0.3021
-$0.0369 (-10.88%)
Today
$0.3021 $0.3400
$0.3021
Past week
$0.3300 $0.3998
from $0.3500 now $0.3021
-$0.0479 (-13.69%)
Past month
$0.3300 $0.4442
from $0.4039 now $0.3021
-$0.1018 (-25.20%)
This year
$0.3021 $1.0500
from $0.7240 now $0.3021
-$0.4219 (-58.27%)

Price & Performance

-0.45 (-60.00%) / 6M

$0.2502$0.5010$0.7517$1.00May 1Aug 3Oct 30

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 97.0% away from all-time highs of $10.0000
  • PMCB is down 58% since the beginning of the year
  • PMCB is down 68% over the past 12 months
  • PMCB is down 25% over the past 1 month
  • 1% of all PMCB investors are betting against PMCB

PMCB reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -67.5%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.5389
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Enterprise value $-25058000.0
Beta 1.22

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$30.5M
DebtN/A
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $3.2M

PharmaCyte Biotech, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatments for cancer and diabetes. It focuses on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box, which will be used as a platform for the development of treatments for inoperable pancreatic cancer and other solid cancerous tumors, and diabetes. The company was founded on October 28, 1996 and is headquartered in Las Vegas, NV.

Competitor comparison

TickerCompany PriceChange
CSLLY CSL Limited Sponsored ADR $35.39 +1.11%
ARGX argenx SE Sponsored ADR $892.87 -0.55%
ONC BeOne Medicines Ltd. Sponsored ADR $370.33 -0.33%
INCY Incyte Corporation $120.39 +3.07%
WXIBF Wuxi Biologics (Cayman) Inc. $5.69 -3.64%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.